Association between lipid accumulation product and non-alcoholic fatty liver disease with normal weight: a population-based study

Association between lipid accumulation product and non-alcoholic fatty liver disease with normal weight: a population-based study

BackgroundPrevious studies have indicated that Lipid accumulation product (LAP) can serve as a predictor for various metabolic diseases. However, the relationship between LAP and Non-alcoholic fatty liver disease (NAFLD) in individuals with normal weight remains unclear.MethodsThis study involves a...

Full description

Saved in:

Bibliographic Details
Main Authors:	Lingde Shen, Yuanfang Lin, Weifeng Chen, Hui Peng
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2025-08-01
Series:	Frontiers in Medicine
Subjects:	lipid accumulation product non-alcoholic fatty liver disease normal weight LAP NAFLD
Online Access:	https://www.frontiersin.org/articles/10.3389/fmed.2025.1565997/full
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Study of association and diagnostic utility of novel anthropometric and lipid indices for nonalcoholic fatty liver disease: A hospital-based study
by: Anand K. Pyati, et al.
Published: (2025-06-01)

Lactate transporter MCT4 regulates the hub genes for lipid metabolism and inflammation to attenuate intracellular lipid accumulation in non-alcoholic fatty liver disease
by: Yannian Gou, et al.
Published: (2025-07-01)

Effect of water extract of bay laurel (Laurus nobilis L.) on non-alcoholic fatty liver disease (NAFLD)
by: Minhee Lee, et al.
Published: (2025-04-01)

Exercise ameliorates hepatic lipid accumulation via upregulating serum PRL and activating hepatic PRLR-mediated JAK2/STAT5 signaling pathway in NAFLD mice
by: Jia Fan, et al.
Published: (2025-08-01)

Caveolin 1 in bovine liver is associated with fatty acid–induced lipid accumulation and the endoplasmic reticulum unfolded protein response: Role in fatty liver development
by: Ming Li, et al.
Published: (2025-01-01)

Prevalence and Profile of Fibrosis in Diabetic Patients with Non-alcoholic Fatty Liver Disease and the Associated Factors
by: Ignatius Bima Prasetya, et al.
Published: (2017-08-01)

Prevalence and Profile of Fibrosis in Diabetic Patients with Non-alcoholic Fatty Liver Disease and the Associated Factors
by: Ignatius Bima Prasetya, et al.
Published: (2017-08-01)

Practical Aspects of Clinical Manifestations, Pathogenesis and Therapy of Alcoholic Liver Disease and Non-alcoholic Fatty Liver Disease: Expert Opinion
by: V. V. Tsukanov, et al.
Published: (2023-11-01)

NON-ALCOHOLIC FATTY LIVER DISEASE OUTCOMES FUNNEL
by: D. V. Blinov
Published: (2015-12-01)

Profile of Children With Non-alcoholic Fatty Liver Disease Referred to a Hospital in Iran
by: Amin Ghanbari, et al.
Published: (2024-12-01)

Gut microbiome in non-alcoholic fatty liver disease
by: Anastasios Mpountouridis, et al.
Published: (2025-01-01)

The action of Poria cocos polysaccharides against non-alcoholic fatty liver disease: A preliminary study
by: Rui Zhou, et al.
Published: (2025-12-01)

Lipid metabolism indicators provide tools for the diagnosis of non-alcoholic fatty liver disease: results of a nationwide survey
by: Yongxin Wang, et al.
Published: (2025-01-01)

A simple, reliable and easily generalizable cell-based assay for screening potential drugs that inhibit lipid accumulation
by: Weili Yang, et al.
Published: (2025-01-01)

Ethanol extract of Garcinia kola seeds alleviates HGHFD/STZ-induced nonalcoholic fatty liver disease in diabetic rats by modulating oxidative stress, inflammation, and lipid accumulation
by: Xiaojing Sun, et al.
Published: (2025-05-01)

Prevalence and association of non-alcoholic fatty liver disease and insulin resistance among non-diabetic obese, overweight, and metabolically obese normal-weight adult patients attending at a tertiary care hospital in Eastern India
by: Samik Pramanik, et al.
Published: (2025-02-01)

The Interplay of Iron and Lipid Homeostasis in Non-Alcoholic Fatty Liver Disease
by: Clinton J. Kidman, et al.
Published: (2025-03-01)

PREVALENCE OF NON-ALCOHOLIC FATTY LIVER DISEASE IN REPUBLIC OF BASHKORTOSTAN (REGIONAL RESULTS OF DIREG 2 STUDY)
by: D. Kh. Kalimullina, et al.
Published: (2017-03-01)

Lipid profile and non-alcoholic fatty liver disease detected by ultrasonography: is systemic inflammation a necessary mediator?
by: Wenzhen Li, et al.
Published: (2025-12-01)

Fucoidan ameliorates lipid accumulation, oxidative stress, and NF-κB-mediated inflammation by regulating the PI3K/AKT/Nrf2 signaling pathway in a free fatty acid-induced NAFLD spheroid model
by: Xueru Chu, et al.
Published: (2025-02-01)

Ginseng and its functional components in non-alcoholic fatty liver disease: therapeutic effects and multi-target pharmacological mechanisms
by: Ping Xiao, et al.
Published: (2025-04-01)

Targeting the gut microbiota and lipid metabolism: potential mechanisms of natural products for the treatment of non-alcoholic fatty liver disease
by: Yutian Zhang, et al.
Published: (2025-06-01)

EPIDEMIOLOGICAL FEATURES OF NON-ALCOHOLIC FATTY LIVER DISEASE IN NOVOSIBIRSK (SIBERIAN FEDERAL DISTRICT): REGIONAL DATA OF OPEN MULTICENTER PROSPECTIVE STUDY DIREG 2
by: V. V. Tsukanov, et al.
Published: (2016-09-01)

Current concepts of the pathogenesis of non-alcoholic fatty liver disease
by: Evgenia Pavlovna Kosobyan, et al.
Published: (2010-03-01)

Prevalence of non-alcoholic fatty liver disease in out-patients of the Russian Federation: DIREG 2 study results
by: V. T. Ivashkin, et al.
Published: (2015-12-01)

The relationship between anthropometric indices and non-alcoholic fatty liver disease in adults: a cross-sectional study
by: Mina Radmehr, et al.
Published: (2025-01-01)

The triterpenoids-enriched extracts from Antrodia cinnamomea mycelia attenuate alcohol-induced chronic liver injury via suppression lipid accumulation in C57BL/6 mice
by: Yange Liu, et al.
Published: (2021-07-01)

Association between oxidative stress and liver fibrosis severity in non-alcoholic fatty liver disease: insights from the pro-oxidant antioxidant balance method in a population from Tehran and Mashhad, Iran
by: Hami Ashraf, et al.
Published: (2025-03-01)

THE PREVALENCE OF NON-ALCOHOLIC FATTY LIVER DISEASE IN OUTPATIENTS IN THE FAR EAST FEDERAL DISTRICT
by: V. A. Nevzorova, et al.
Published: (2017-05-01)

Metabolic Syndrome in Adults with Nonalcoholic Fatty Liver Disease
by: Zhahid Hassan, et al.
Published: (2021-09-01)

Prevalence of non-alcoholic fatty liver disease among inflammatory bowel disease patients: a systematic review and meta-analysis
by: Yuyang Zhao, et al.
Published: (2025-07-01)

Metabolic and Genetic Determinants of Lipid Metabolism Disruption in Non-Alcoholic Fatty Liver Disease
by: O. Yu. Kytikova, et al.
Published: (2020-05-01)

Pathogenic role of lipids in non-alcoholic fatty liver disease
by: Yu. O. Shulpekova
Published: (2012-02-01)

Drug Repurposing for Non-Alcoholic Fatty Liver Disease by Analyzing Networks Among Drugs, Diseases, and Genes
by: Md. Altaf-Ul-Amin, et al.
Published: (2025-04-01)

Diagnostic and pathogenetic significance of apolipoprotein disorders in patients with alcoholic fatty liver
by: Mladenović Bojan, et al.
Published: (2017-01-01)

Adherence to plant based diets reduce the risk of hepatic fibrosis in nonalcoholic fatty liver disease
by: Mahsa Miryan, et al.
Published: (2025-05-01)

Systems metabolic insights into kaempferol-mediated alleviation of alcoholic fatty liver disease
by: Chenmeng Song, et al.
Published: (2025-05-01)

A prediction model of liver fat fraction and presence of non-alcoholic fatty liver disease (NAFLD) among patients with overweight or obesity
by: Jie Chen, et al.
Published: (2023-10-01)

Erhong Jiangzhi Decoction Inhibits Lipid Accumulation and Alleviates Nonalcoholic Fatty Liver Disease with Nrf2 Restoration Under Obesity
by: Li F, et al.
Published: (2024-12-01)

Association between overactive bladder and lipid accumulation product and visceral adiposity index: results from NHANES 2005–2018
by: Wenhao Wang, et al.
Published: (2025-07-01)